HTA Database - Search Results

Sort by Relevance

Search Results [1526 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2026	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Newborn screening for metachromatic leukodystrophy]
2026	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Review of the lower age limit and frequency of early-detection colonoscopy in the colorectal cancer screening programme]
2026	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Safety, clinical effectiveness and cost-effectiveness of neonatal screening for Pompe disease]
2026	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Evaluation of the safety, clinical and cost-effectiveness of neonatal screening for type 1 citrullinaemia, trifunctional protein deficiency, holocarboxyl synthetase deficiency, argininosuccinic aciduria and 3-methylcrotonyl-CoA carboxylase deficiency]
2026	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Safety, clinical effectiveness, and cost-effectiveness of neonatal screening for beta-ketothiolase deficiency and classic galactosemia. Update]
2025	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Effectiveness and complications of preimplantation genetic testing for aneuploidies (PGT-A) in in vitro fertilisation (IVF)]
2025	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Early detection of colorectal cancer in people with a family risk]
2025	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Revision of the information materials on colorectal cancer screening]
2025	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Assesment of artificial intelligence´s diagnostic yield and security in cardiac monitoring using insertable cardiac monitors]
2025	Belgian Health Care Knowledge Centre (KCE)	Update of breast cancer screening recommendations (Study 2024-11)
2025	Belgian Health Care Knowledge Centre (KCE)	Update of prostate cancer screening recommendations (Study 2024-10)
2025	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Consumer health information on lung cancer screening using low-dose computed tomography]
2025	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Newborn screening for Metachromatic leukodystrophy (MLD)]
2025	NIHR Health and Social Care Delivery Program	Systematic review of integrated mental and physical health services for children and young people with eating and functional symptoms
2025	NIHR Health Technology Assessment programme	Multi-cancer early detection tests for general population screening: a systematic literature review
2025	NIHR Health Services and Delivery Research programme	Cancer in English prisons: a mixed-methods study of diagnosis, treatment, care costs and patient and staff experiences
2025	NIHR Health Technology Assessment programme	Management of diarrhoea in patients with stable ulcerative colitis with low FODMAP diet, amitriptyline, ondansetron or loperamide: the MODULATE RCT
2025	NIHR Health Technology Assessment programme	The acceptability of blood spot screening and genome sequencing in newborn screening: a systematic review examining evidence and frameworks
2025	NIHR Health Technology Assessment programme	Lessons from the PROTECT-CH COVID-19 platform trial in care homes
2025	NIHR Health Technology Assessment programme	Supporting self-management with an internet intervention for low back pain in primary care: a RCT (SupportBack 2)
2025	NIHR Health and Social Care Delivery Program	Direct oral penicillin challenge in secondary care with low-risk patients: the SPACE mixed-methods study with cost-effectiveness analysis
2025	NIHR Health and Social Care Delivery Program	Approaches used to prevent and reduce the use of restrictive practices on adults with learning disabilities: a realist review
2025	NIHR Health and Social Care Delivery Program	Opportunities and practices supporting responsive health care for forced migrants: lessons from transnational practice and a mixed-methods systematic review
2025	Technology Assessment at SickKids (TASK)	A micro-costing and cost consequence analysis from a randomized controlled trial comparing genome sequencing to exome sequencing for genetic diagnosis
2025	Institut national d'excellence en sante et en services sociaux (INESSS)	[Relevance of adding vitamin-dependent rickets screening to neonatal screening]
2025	NIHR Health Technology Assessment programme	Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trial
2025	NIHR Health Technology Assessment programme	Software with artificial intelligence-derived algorithms for detecting and analysing lung nodules in CT scans: systematic review and economic evaluation
2025	NIHR Health Technology Assessment programme	Ivacaftor–tezacaftor–elexacaftor, tezacaftor–ivacaftor and lumacaftor–ivacaftor for treating cystic fibrosis: a systematic review and economic evaluation
2025	NIHR Health Services and Delivery Research programme	Co-designing and testing the learn together guidance to support patient and family involvement in patient safety investigations: a mixed-methods study
2025	NIHR Health Technology Assessment programme	Clinical and cost-effectiveness of detailed anomaly ultrasound screening in the first trimester: a mixed-methods study
2025	Institut national d'excellence en sante et en services sociaux (INESSS)	[Food allergen-specific IgG4 (immunoglobulin G4) measurement by immunoassay]
2025	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Evaluation of genetic tests related to hearing loss and their role in neonatal population screening]
2025	NIHR Health Services and Delivery Research programme	How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis
2025	Health Technology Wales (HTW)	Smartphone based photoplethysmography for the detection and monitoring of atrial fibrillation
2025	NIHR Health Technology Assessment programme	Challenges to overcome in a randomised trial for Proper Understanding of Recurrent Stress Urinary Incontinence Treatment in women: the PURSUIT RCT
2025	NIHR Health Technology Assessment programme	Ambulatory oxygen for pulmonary fibrosis (OxyPuF): a randomised controlled trial and acceptability study
2025	NIHR Health Technology Assessment programme	Variation within and between digital pathology and light microscopy for the diagnosis of histopathology slides: blinded crossover comparison study
2025	NIHR Health Technology Assessment programme	Digital augmentation of aftercare for patients with anorexia nervosa: the TRIANGLE RCT and economic evaluation
2025	NIHR Health Technology Assessment programme	Medical management and intervention (using neurosurgical resection or stereotactic radiosurgery) versus medical management alone for symptomatic brain cavernoma: the CARE pilot RCT
2025	NIHR Health Technology Assessment programme	Determining optimal strategies for primary prevention of cardiovascular disease: a synopsis of an evidence synthesis study
2025	NIHR Health and Social Care Delivery Program	Meeting the needs of women in the perinatal period, who use or are in treatment for using drugs: a mixed-methods systematic review
2025	NIHR Health Technology Assessment programme	Perioperative oxygen therapy in patients undergoing surgical procedures: an overview of systematic reviews and meta-analyses
2025	Institut national d'excellence en sante et en services sociaux (INESSS)	[Access to breast cancer screening for Québec women aged 40 to 49: issues, considerations and implementation approach]
2025	NIHR Health Technology Assessment programme	Algorithm-based remote monitoring of heart failure risk data in people with cardiac implantable electronic devices: a systematic review and cost-effectiveness analysis
2025	Austrian Institute for Health Technology Assessment (AIHTA)	Further development of the program on preventive health check-ups: screening for chronic kidney disease – a rapid review of benefits, harms and target populations
2025	NIHR Health Technology Assessment programme	Microfracture with or without collagen scaffold insertion for adults with chondral or osteochondral defects of the knee: the SISMIC RCT and its challenges during and after the COVID-19 pandemic
2025	Institut national d'excellence en sante et en services sociaux (INESSS)	[Relevance of adding screening for vitamin D-dependent rickets to the Quebec Neonatal Blood Screening Program]
2025	NIHR Health Technology Assessment programme	Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension: CONFORM-OH pilot RCT and economic evaluation
2025	NIHR Health Technology Assessment programme	Effectiveness of Escitalopram and Nortriptyline on Depressive Symptoms in Parkinson’s disease: the ADepT-PD RCT pilot
2025	NIHR Health Technology Assessment programme	Clinical and cost-effectiveness of technologies for the assessment of attention deficit hyperactivity disorder: a systematic review and economic model
2025	Adelaide Health Technology Assessment (AHTA)	Newborn bloodspot screening for mucopolysaccharidosis Type II (MPS II; Hunter syndrome)
2025	Adelaide Health Technology Assessment (AHTA)	Newborn bloodspot screening for mucopolysaccharidosis, Type 1 (MPS I)
2025	Adelaide Health Technology Assessment (AHTA)	Newborn bloodspot screening for glycogen storage disease, Type II (GSD II; Pompe disease)
2025	NIHR Health Technology Assessment programme	Evaluating whole genome sequencing for rare diseases in newborn screening: evidence synthesis from a series of systematic reviews
2025	Malaysian Health Technology Assessment (MaHTAS)	Microwave ablation for kidney and liver tumours
2024	Belgian Health Care Knowledge Centre (KCE)	The use of endothelial cell count in the preoperative evaluation of cataract surgery
2024	Belgian Health Care Knowledge Centre (KCE)	Lung cancer screening in a high-risk population
2024	NIHR Health Technology Assessment programme	A tailored psychological intervention for anxiety and depression management in people with chronic obstructive pulmonary disease: TANDEM RCT and process evaluation
2024	NIHR Health Services and Delivery Research programme	Factors within the clinical encounter that impact upon risk assessment within child and adolescent mental health services: a rapid realist synthesis
2024	NIHR Health Technology Assessment programme	Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
2024	Basque Office for Health Technology Assessment (OSTEBA)	[Use of self-sampling for the detection of human papillomavirus in cervical cancer screening]
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: dosing of a new generation anti-seizure panel by LC-MS/MS]
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guides and standards: type 2 diabetes screening and cardiovascular risk assessment]
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of adding newborn screening for congenital adrenal hyperplasia to the Quebec newborn blood screening program]
2024	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Early detection of vitamin B12 deficiency and other target diseases (homocystinuria, propionic acidaemia and methylmalonic acidaemia) in extended newborn screening (ENS)]
2024	NIHR Health Technology Assessment programme	A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial)
2024	NIHR Health Technology Assessment programme	Lower urinary tract symptoms in men: the TRIUMPH cluster RCT
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guides and standards: urethral discharge - diagnostic measures and pharmacological treatment]
2024	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Screening for the early detection of familial hypercholesterolaemia in children and adolescents]
2024	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Target group-specific approach to insured persons during health check-ups]
2024	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Assessment of lung cancer screening using low-dose computed tomography]
2024	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Multi-stage evaluation and revision of information materials on the mammography screening programme]
2024	NIHR Health Services and Delivery Research programme	Reducing health inequalities through general practice: a realist review and action framework
2024	NIHR Health Technology Assessment programme	Prehospital early warning scores for adults with suspected sepsis: the PHEWS observational cohort and decision-analytic modelling study
2024	NIHR Health Technology Assessment programme	Patient-reported outcome measures for monitoring primary care patients with depression: the PROMDEP cluster RCT and economic evaluation
2024	NIHR Health Technology Assessment programme	Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guides and standards: unusual vaginal discharge - diagnostic measures and pharmacological treatment]
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of adding universal screening for congenital cytomegalovirus (CMV) infection to Québec newborn screening program]
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Methodology report: development and evaluation of a software tool based on GPT-4 to help sort documents for literature reviews - a proof of concept]
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guides and standards: initiating an HPV test and following up on results for cervical cancer screening]
2024	National Evidence-based Healthcare Collaborating Agency (NECA)	[Artificial intelligence-based screening test for emergent large vessel occlusion using non-contrast brain CT images]
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: equivalence of the positivity threshold of immunochemical fecal occult blood tests for colorectal cancer screening]
2024	NIHR Health Services and Delivery Research programme	Causes and solutions to workplace psychological ill-health for nurses, midwives and paramedics: the Care Under Pressure 2 realist review
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guides and standards: delirium in elderly persons in emergency departments - prevention, assessment and management]
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: judicious use of medical biology tests in the diagnosis and treatment of Helicobacter pylori infection]
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: linezolid plasma dosing]
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: breast cancer screening with breast tomosynthesis]
2024	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Early screening in pregnant women with risk factors: Evidence report for the S3 guideline on gestational diabetes mellitus (GDM) – diagnosis, treatment and follow-up care]
2024	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[General screening: Evidence report for the S3 guideline on gestational diabetes mellitus (GDM) – diagnosis, treatment and follow-up care]
2024	HTA South	[Artificial intelligence in breast cancer screening with mammography]
2024	Health Information and Quality Authority (HIQA)	Evidence review of universal ultrasound screening for developmental dysplasia of the hip (DDH) in infants in Ireland
2024	Health Information and Quality Authority (HIQA)	Protocol for a health technology assessment of screening for abdominal aortic aneurysm in men
2024	Penn Medicine Center for Evidence-based Practice (CEP)	Interventions to prevent aspiration pneumonia in non-ventilated hospitalized patients
2024	NIHR Health Technology Assessment programme	Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Checklist: screening for cancers, chronic diseases and STBBIs]
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guides and standards: initiating osteodensitometry following the assessment of fracture risk with the FRAX tool]
2024	NIHR Health Technology Assessment programme	Reducing self-harm in adolescents: the RISA-IPD individual patient data meta-analysis and systematic review
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: carrier screening - disease selection, considerations, and ethical, psychosocial, sociocultural, organizational, and economic issues]
2024	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of adding a genetic variant of mucolipidosis type II to the carrier testing offer for people from the Saguenay-Lac-Saint-Jean, Charlevoix, and Haute-Côte-Nord regions]
2024	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Diagnostic accuracy of impulse oscillometry (IOS) compared to spirometry]